Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 7
1978 10
1979 29
1980 37
1981 31
1982 38
1983 29
1984 35
1985 44
1986 36
1987 36
1988 28
1989 46
1990 28
1991 23
1992 20
1993 18
1994 23
1995 23
1996 23
1997 13
1998 26
1999 15
2000 17
2001 16
2002 16
2003 23
2004 22
2005 34
2006 27
2007 17
2008 37
2009 33
2010 45
2011 49
2012 37
2013 55
2014 45
2015 43
2016 46
2017 43
2018 43
2019 40
2020 55
2021 60
2022 53
2023 36
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

1,409 results

Results by year

Filters applied: . Clear all
Page 1
Fetal Hemoglobin Regulation in Beta-Thalassemia.
Lu HY, Orkin SH, Sankaran VG. Lu HY, et al. Hematol Oncol Clin North Am. 2023 Apr;37(2):301-312. doi: 10.1016/j.hoc.2022.12.002. Hematol Oncol Clin North Am. 2023. PMID: 36907604 Review.
Molecular genetics of β-thalassemia: A narrative review.
Jaing TH, Chang TY, Chen SH, Lin CW, Wen YC, Chiu CC. Jaing TH, et al. Medicine (Baltimore). 2021 Nov 12;100(45):e27522. doi: 10.1097/MD.0000000000027522. Medicine (Baltimore). 2021. PMID: 34766559 Free PMC article. Review.
Genome editing approaches to β-hemoglobinopathies.
Brusson M, Miccio A. Brusson M, et al. Prog Mol Biol Transl Sci. 2021;182:153-183. doi: 10.1016/bs.pmbts.2021.01.025. Epub 2021 Mar 1. Prog Mol Biol Transl Sci. 2021. PMID: 34175041
Exagamglogene Autotemcel: First Approval.
Hoy SM. Hoy SM. Mol Diagn Ther. 2024 Mar;28(2):133-139. doi: 10.1007/s40291-024-00696-z. Epub 2024 Jan 17. Mol Diagn Ther. 2024. PMID: 38228954 Review.
Determinants of severity in sickle cell disease.
Rees DC, Brousse VAM, Brewin JN. Rees DC, et al. Blood Rev. 2022 Nov;56:100983. doi: 10.1016/j.blre.2022.100983. Epub 2022 Jun 9. Blood Rev. 2022. PMID: 35750558 Free article. Review.
Induction of Fetal Hemoglobin by Gene Therapy.
Walters MC. Walters MC. N Engl J Med. 2021 Jan 21;384(3):284-285. doi: 10.1056/NEJMe2034338. N Engl J Med. 2021. PMID: 33471981 No abstract available.
Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling.
De Souza DC, Hebert N, Esrick EB, Ciuculescu MF, Archer NM, Armant M, Audureau É, Brendel C, Di Caprio G, Galactéros F, Liu D, McCabe A, Morris E, Schonbrun E, Williams D, Wood DK, Williams DA, Bartolucci P, Higgins JM. De Souza DC, et al. Nat Commun. 2023 Sep 20;14(1):5850. doi: 10.1038/s41467-023-40923-5. Nat Commun. 2023. PMID: 37730674 Free PMC article.
A New Trans-Acting Modulator of Fetal Hemoglobin?
Steinberg MH. Steinberg MH. Acta Haematol. 2018;140(2):112-113. doi: 10.1159/000492147. Epub 2018 Sep 18. Acta Haematol. 2018. PMID: 30227393 Free article. No abstract available.
Keeping fetal hemoglobin in the loop.
Grevet JD, Blobel GA. Grevet JD, et al. Cell Cycle. 2014;13(20):3153-4. doi: 10.4161/15384101.2014.969995. Cell Cycle. 2014. PMID: 25485488 Free PMC article. No abstract available.
1,409 results